Jalil Rashedi
Impact in
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
- COVID-19 Clinical Research Studies
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
Papers in
-
- Tuberculosis Research and Epidemiology 19
- COVID-19 Clinical Research Studies 5
- Epidemiology 15
- Mycobacterium research and diagnosis 10
- Pneumocystis jirovecii pneumonia detection and treatment 4
- Co-authors
- Mohammad Asgharzadeh (40 shared papers)Hossein Samadi Kafil (29 shared papers)Davoud Sanajou (6 shared papers)Amir Ghorbani Haghjo (5 shared papers)Mehran Mesgari Abbasi (4 shared papers)Leila Roshangar (4 shared papers)Hassan Argani (4 shared papers)Saeed Nazari Soltan Ahmad (4 shared papers)
In The Last Decade
Jalil Rashedi
50 papers receiving 494 citations
Peers
Comparison fields: 5 of 106
- Infectious Diseases 177
- Clinical Biochemistry 43
- Endocrinology, Diabetes and Metabolism 80
- Nephrology 29
- Pathology and Forensic Medicine 58
Countries citing papers authored by Jalil Rashedi
This map shows the geographic impact of Jalil Rashedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jalil Rashedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jalil Rashedi more than expected).
Fields of papers citing papers by Jalil Rashedi
This network shows the impact of papers produced by Jalil Rashedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jalil Rashedi. The network helps show where Jalil Rashedi may publish in the future.
Co-authors
The 25 scholars most cited alongside Jalil Rashedi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 79 | |
| 2 | Risk Factors for COVID-19. | 2020 | 67 |
| 3 | 2019 | 45 | |
| 4 | 2014 | 32 | |
| 5 | 2018 | 25 | |
| 6 | 2018 | 24 | |
| 7 | 2018 | 18 | |
| 8 | Multidrug-resistant tuberculosis in north-west of Iran and Republic of Azerbaijan: a major public health concern for Iranian people. | 2015 | 17 |
| 9 | Cytotoxic effect of rosemary extract on gastric adenocarcinoma (AGS) and esophageal squamous cell carcinoma (KYSE30) cell lines. | 2017 | 15 |
| 10 | 2020 | 13 | |
| 11 | 2019 | 13 | |
| 12 | Association of Promoter Polymorphisms of Interleukin-10 and Interferon-Gamma Genes with Tuberculosis in Azeri Population of Iran. | 2016 | 12 |
| 13 | 2019 | 12 | |
| 14 | 2021 | 11 | |
| 15 | 2020 | 11 | |
| 16 | Molecular Characterization of Cryptosporidium Species in Children with Diarrhea in North West of Iran. | 2015 | 10 |
| 17 | An unusual hypersensitivity reaction to chlorhexidine. | 1986 | 8 |
| 18 | 2018 | 7 | |
| 19 | 2020 | 7 | |
| 20 | 2016 | 6 |
About Jalil Rashedi
Jalil Rashedi is a scholar working on Infectious Diseases, Epidemiology, Surgery, Molecular Biology and Pathology and Forensic Medicine, having authored 54 papers that have together received 507 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (19 papers), Mycobacterium research and diagnosis (10 papers), Diagnosis and treatment of tuberculosis (7 papers), Infectious Diseases and Tuberculosis (7 papers), COVID-19 Clinical Research Studies (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Multiple Sclerosis Research Studies (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). The work is most often cited by research in Infectious Diseases (177 citations), Clinical Biochemistry (43 citations), Endocrinology, Diabetes and Metabolism (80 citations), Nephrology (29 citations) and Pathology and Forensic Medicine (58 citations). Jalil Rashedi has collaborated with scholars based in Iran, Denmark and Croatia. Frequent co-authors include Mohammad Asgharzadeh, Hossein Samadi Kafil, Davoud Sanajou, Amir Ghorbani Haghjo, Mehran Mesgari Abbasi, Leila Roshangar, Hassan Argani, Saeed Nazari Soltan Ahmad, Nadereh Rashtchizadeh and Hamid Tayebi Khosroshahi. Their work appears in journals such as Infectious Disorders - Drug Targets, Advanced Pharmaceutical Bulletin, Lung, Journal of Physiology and Biochemistry and Parasitology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.